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Abstract 
 
Background: We previously described the high prevalence and burden of significant autistic traits (ATs) in youth with 
attention-deficit/hyperactivity disorder (ADHD). These traits are associated with significantly greater impairment in 
psychopathological, interpersonal, educational, and neuropsychological functioning. Because the sample consisted of referred 
ADHD youth, uncertainty remained regarding whether these findings are generalizable to non-referred populations of youths 
with and without ADHD. 
Objective: The aim of the current study was to assess the prevalence and implications of ATs in a non-referred population 
of siblings of probands with and without ADHD. 
Method: Participants were non-referred siblings of probands with ADHD (N = 257) and control probands (N = 234) of 
longitudinal, case-control family studies conducted at Massachusetts General Hospital. Assessments included measures of 
psychiatric, psychosocial, educational, and cognitive functioning. The presence of significant ATs was operationalized using 
the Child Behavior Checklist AT profile, which consists of combined aggregate T-scores of ≥ 195 on the Withdrawn, Social, 
and Thought Problems subscales. 
Results: ATs were significantly more prevalent among the siblings of probands with ADHD as compared with siblings of 
control probands (6% vs. 1%; P = .02). Siblings of probands with ADHD with a positive AT profile (N = 15) were significantly 
more impaired than those without an AT profile (N = 242) with regard to psychopathological, interpersonal, educational, and 
neuropsychological functioning.  
Conclusions: The current study reports a higher-than-expected prevalence of ATs in a non-referred sample of siblings of 
youth with ADHD, which is consistent with previous findings regarding ATs in a referred sample of youth with ADHD. The 
presence of ATs is associated with higher levels of morbidity and dysfunction. 
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Introduction 
Both attention-deficit/hyperactivity disorder 
(ADHD) and autism spectrum disorder (ASD) have 
strong heritable components. Although their 
underlying etiologies are yet to be fully elucidated, 
evidence from twin and family studies indicate 
shared heritability (1,2). Individuals with ADHD may 
manifest different forms of ASD, from a fully 
developed syndromic form to a milder form of ASD 
symptomatology that involves the exhibition of 
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autistic traits (ATs). However, in contrast with the 
well-developed literature addressing ASD, much less 
is known about the morbidity and dysfunction 
associated with ATs for individuals with and without 
ADHD. 
Recent studies have shown that symptoms of 
autism or ATs appear in 20% to 30% of children with 
ADHD (3-5). Children with ADHD and ATs appear 
to be more impaired and dysfunctional than children 
with ADHD and no ATs. With these literature 
findings in mind, we assessed the prevalence and 
correlates of ATs in youth with and without ADHD, 
with a diagnosis of autism being exclusionary (6). 
ATs were operationalized with the use of a profile 
from the Child Behavior Checklist (CBCL) by using 
extreme values from the sums of the Withdrawn, 
Social, and Thought Problems T-scores (7).  
In the prior study, a positive AT profile was 
significantly more prevalent among children with 
ADHD as compared with control children (18% vs. 
0.87%; p < .01). Children with ADHD with positive 
AT profiles were significantly more impaired than 
other children with ADHD and control children with 
regard to psychopathology and interpersonal, school, 
family, and cognitive functioning. However, because 
our results and the results of previous reports 
examined ATs in referred samples of children with 
ADHD (3-5), it remains unknown whether these 
findings can be generalized to non-referred samples 
of children with and without ADHD. Studies of such 
samples would allow clinicians to identify children at 
high risk for adverse outcomes in multiple domains 
of functioning. This information could further lead 
to the development of appropriate intervention 
strategies aimed at mitigating the adverse outcomes 
associated with ATs.  
The aim of the current study was to examine both 
the prevalence and correlates of ATs in non-referred 
youth with and without ADHD. To this end, we used 
data from an existing large-scale sample of non-
referred siblings of probands with and without 
ADHD. On the basis of the findings in probands, we 
hypothesized that ATs would be identifiable in non-
referred siblings and that the presence of ATs would 
be associated with higher levels of morbidity and 
dysfunction.  
 
Methods 
Subjects 
Subjects were youth of both sexes who had been 
enrolled in longitudinal case-control family studies 
conducted at Massachusetts General Hospital (8,9). 
These studies included probands between the ages of 
6 and 18 years with (N = 280) and without (N = 242) 
ADHD according to Diagnostic and Statistical Manual 
of Mental Disorders, Third Edition, Revised, criteria as 
determined by pediatric and psychiatric sources. 
Adoption, unavailable nuclear family, major 
sensorimotor handicaps, psychosis, autism, language 
barriers, estimated intelligence quotients of less than 
80 were exclusionary for both probands with ADHD 
and control probands. Parents provided written 
informed consent, and children and adolescents 
provided written assent. The institutionnal review 
board at Massachusetts General Hospital approved 
the study. The present analysis relied on the non-
referred siblings of these probands (N = 395 siblings 
of probands with ADHD; N = 317 siblings of 
control probands). Siblings with estimated 
intelligence quotients of less than 80 were excluded 
from the present analysis. 
 
Assessment Procedures 
We used an empirically derived profile from the 
CBCL to define ATs (CBCL-AT) by using a cutoff 
of 195 or more from the combined T-scores of the 
Withdrawn, Social Problems, and Thought Problems 
subscales. We previously reported that this profile 
correctly classified 78% of all subjects with ASD in a 
psychiatrically referred sample of youth with and 
without ASD (7). CBCL emotional dysregulation 
profiles were created from the combined T-scores of 
the Anxiety/Depression, Aggression, and Attention 
subscales. Deficient emotional self-regulation was 
defined as a combined T-score of 180 or more but 
less than 210; severe emotional dysregulation was 
defined as a combined T-score of 210 or more. 
Psychiatric assessments relied on the Kiddie 
Schedule for Affective Disorders and Schizophrenia 
for School-Age Children, Epidemiological Version 
(K-SADS-E) (10,11). Indirect interviews were 
conducted with each subject’s parent or guardian, 
usually the mother. Direct interviews were conducted 
with subjects who were at least 12 years old. After 
combining data from direct and indirect interviews, a 
diagnosis was considered positive if it was endorsed 
in either interview.  
Interviews were administered by highly trained and 
closely supervised raters with bachelor’s or master’s 
degrees in psychology or related fields. Raters were 
blinded to the referral source and the proband’s 
diagnostic status (i.e., ADHD vs. control). On the 
basis of 500 assessments obtained via interviews of 
children and adults, the median κ coefficient of 
agreement between a rater and an experienced 
clinician was 0.98.  
The parent or guardian also provided information 
about pregnancy and delivery history and the child’s 
infancy. Socioeconomic status (SES) was established 
using categories delineated by Hollingshead (12). The 
Global Assessment of Functioning (GAF) scale was 
used to measure overall adaptive functioning (13,14). 
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Interpersonal and psychosocial functioning was 
assessed with the use of the Social Adjustment 
Inventory for Children and Adolescents (SAICA) 
(15). To better gauge social difficulties, we computed 
an index of social dysfunction that we previously 
called Social Disability. This index was computed with 
the use of methodology recommended by Reynolds 
(16); it was previously implemented by our team to 
assess learning disabilities on the basis of the 
discrepancy between the expected SAICA scaled 
score (derived from the estimated full-scale 
intelligence quotient) and the actual SAICA scaled 
score (17).  
To evaluate school functioning, three indices of 
school difficulties were used: placement in special 
classes, extra tutoring, and repeated grades as 
reported by the parent or guardian.  
Intellectual functioning was assessed through the 
Vocabulary, Block Design, Digit Span, Digit Symbol, 
Digit Coding, and Arithmetic subtests of the 
Wechsler Intelligence Scale for Children–Revised 
(WISC-R) (18). By using procedures suggested by 
Sattler (19), we estimated the full-scale intelligence 
quotient from the Block Design and Vocabulary 
subtests of the WISC-R using age-corrected scaled 
scores. We computed the Freedom from 
Distractibility intelligence quotient using the Digit 
Span, Digit Coding, and oral Arithmetic subscales of 
the WISC-R. Reading and arithmetic achievement 
were assessed using subtests of the Wide Range 
Achievement Test–Revised (WRAT-R) (20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All Probands 
N = 522 
Siblings of Probands 
N = 712 
Siblings ages 6 - 18 
N = 588 
Siblings with CBCL 
data 
N = 491 
Siblings of Control 
Probands 
N = 234 
Siblings of ADHD 
Probands 
N = 257 
Siblings without ATs 
N = 231 
Siblings with ATs 
N = 3 
Siblings without ATs 
N = 242 
Siblings with ATs 
N = 15 
FIGURE 1. PRISMA diagram. Siblings were excluded if they were not 6 – 18 years old or if they were missing CBCL data. Our 
final sample was restricted to the siblings of ADHD probands because only 3 siblings of control probands had ATs  
Siblings excluded:  
too young or too old 
N = 124 
Siblings excluded: 
missing CBCL data 
N = 97 
All siblings of Control 
probands excluded due to 
small number with ATs 
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Statistical Analyses 
All analyses were performed using regression models 
with robust standard errors to account for the non-
independence of siblings. Differences in 
sociodemographic characteristics were assessed with 
the use of linear regression for continuous outcomes 
and logistic regression for binary outcomes. We 
controlled for any demographic confounder that 
reached significance at the 0.05 alpha level. Rates of 
ATs in siblings of probands with ADHD and control 
probands were analyzed using logistic regression. 
Analyses for psychiatric disorders, emotional 
dysregulation, school functioning, social disability, 
and perinatal complications were performed using 
exact logistic regression with permutation testing to 
deal with the issues of small expected numbers and 
non-independence. Analyses of the CBCL, GAF, 
SAICA, WISC-R, and WRAT-R items were 
performed with the use of linear regression. All tests 
were two-tailed, with the alpha set at 0.05. We 
calculated all statistics using Stata software version 
14.0 (StataCorp, College Station, TX).  
 
Results 
Although there were 712 siblings in total, 221 siblings 
were excluded because they did not meet the age 
criteria of 6 to 18 years or because they were missing 
CBCL information (Figure 1). Thus, our final sample 
included 257 siblings of probands with ADHD and 
234 siblings of control probands. Siblings had mean 
± standard deviation ages of 10.7 ± 3.2 years and 
SES scores of 1.8 ± 0.9. Of the 230 subjects who 
reported their race, 94% were Caucasian. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As shown in Figure 2, rates of ATs were lowest 
among the siblings of control probands, intermediate 
among siblings of probands with ADHD without 
ADHD, and highest among siblings of probands 
with ADHD with ADHD. Siblings of probands with 
ADHD had significantly higher rates of ATs as 
compared with siblings of control probands (6% vs. 
1%; χ2 = 5.92; p = .02). Because only three siblings 
of control probands had positive AT profiles, 
analyses were limited to siblings of probands with 
ADHD with ATs (n = 15) and without ATs (n = 
242). 
a***b***
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FIGURE 2. Rate of ATs in siblings of Control probands (n = 234), siblings of ADHD probands without 
ADHD (n = 201), and siblings of ADHD probands with ADHD (n = 56).  
a
 Compared to siblings of Control 
probands. 
b
 Compared to siblings of ADHD probands without ADHD. *p<0.05, **<0.005, ***p<0.001 
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TABLE 1.  Sociodemographic Characteristics 
Characteristic Sibling without ATs 
N = 242 
Siblings with ATs 
N = 15 
Test Statistic p-Value 
Age 10.6 ± 3.2 9.9 ± 3.4 t(174) = -0.83 0.41 
Sex (Male) 123 (51) 11 (73) X2 = 3.03 0.08 
SES 1.9 ± 0.9 2.3 ± 0.9 X2 = 4.86 0.03 
Data are presented as mean ± SD or n (%) 
 
 
 
 
 
TABLE 2.  Pregnancy and Infancy Characteristics 
 Sibling without 
ATs 
N = 222 
Siblings with ATs 
N = 15 
Test Statistic p-Value 
Pregnancy Characteristics     
 Excessive nausea 48 (22) 3 (20) Exact 0.30 
 Infection 26 (12) 5 (33) Exact <0.001 
 High blood pressure 37 (17) 4 (27) Exact 0.002 
 Accidents 6 (3) 0 (0) Exact 0.04 
 Family Problems 31 (14) 5 (33) Exact <0.001 
 Medications 55 (25) 7 (47) Exact <0.001 
 Smoking ( 3 mo. at gestation) 32 (14) 5 (33) Exact 0.002 
Infancy Characteristics     
 Switch formulas 18 (8) 7 (47) Exact <0.001 
 Crying infant 28 (13) 5 (33) Exact 0.003 
 Stiffened infant 5 (2) 2 (13) Exact <0.001 
Data are presented as mean ± SD or n (%) 
 
 
 
 
Sociodemographic Characteristics 
The siblings with ATs were of similar age and sex as 
the siblings without ATs but were of a more 
disadvantaged SES status. Siblings with ATs scored 
an average of 2.3 on the Hollingshead measure of 
SES as compared with a score of 1.9 for siblings 
without ATs (Table 1). Therefore, all subsequent 
analyses corrected for SES. 
 
Patterns of Psychiatric Comorbidity and 
Psychopathology 
The average number of psychiatric disorders was 
significantly higher for siblings with ATs as 
compared with siblings without ATs (t (174) = 3.68; p 
< .001; Figure 3, A). As compared with siblings 
without ATs, siblings with ATs had a significantly 
higher prevalence of ADHD, other disruptive 
behavior disorders, mood disorders, multiple (two or 
more) anxiety disorders, language disorders, and 
elimination disorders (p < .005 for all; see Figure 3, 
B). Likewise, individual and composite scores on all 
CBCL clinical scales as well as the two CBCL 
emotional dysregulation profiles were significantly 
more impaired among siblings with ATs as compared 
with those without ATs (p ≤ .001 for all; see Figure 
3, C and D).  
 
Psychosocial Functioning 
As compared with siblings without ATs, siblings with 
ATs had significantly more impaired GAF scores (t 
(174) = -4.75; p < .001; Figure 4, A), significantly more 
impaired scores on the CBCL social and school 
competence scales (p < .001 for both; see Figure 4, 
B), significantly more impaired SAICA scaled scores 
on 7 of the 10 subscales (p < .05 for all; see Figure 4, 
C), and a significantly higher prevalence of social 
disability (Exact; p = .001; see Figure 4, D).  
 
School Functioning  
Siblings with ATs were significantly more likely to 
receive tutoring (χ2 = 10.69; p = .001) and to be 
placed in special classes (Exact; p < .001) as 
compared with siblings without ATs (Figure 5, A). 
 
Neuropsychological Functioning 
Siblings with ATs had lower composite cognitive and 
achievement WISC-R and WRAT-R scores than 
siblings without ATs (see Figure 5, B) as well as lower 
scores on the five WISC-R subscales (see Figure 5, 
C). However, these differences failed to reach our a 
priori threshold for statistical significance.  
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Perinatal Complications 
Rates of all but two pregnancy and infancy 
characteristics were significantly higher among 
siblings with ATs as compared with siblings without 
ATs (p < .005 for all), and the rate of accidents during 
pregnancy was significantly lower among siblings 
with ATs (Exact; p = .04; Table 2). 
  
Discussion 
Our findings reveal that ATs can be identified in a 
sizeable number of non-referred children, 
particularly in those with ADHD. The results also 
show that the presence of ATs heralds a significantly 
more compromised clinical presentation that is 
characterized by higher rates of psychopathological, 
neuropsychological, and interpersonal deficits as 
compared with children without these traits. These 
results in non-referred youth are highly consistent 
with the findings of previous reports (3-5) and with 
our findings from probands with ADHD (21). Thus, 
these results provide further support for the clinical 
relevance of ATs, irrespective of referral status.  
Non-referred youth with ATs exhibited 
significantly higher rates of comorbid psycho-
pathology as compared with those without ATs as 
expressed by the significantly higher mean number of 
comorbid psychiatric disorders; the significantly 
higher rates of disruptive behavior, mood, anxiety, 
language, and elimination disorders; the marked 
impairments noted in all individual and composite 
CBCL clinical scales; and higher rates of emotional 
dysregulation. These findings are highly consistent 
with those previously reported for referred probands 
with ADHD with ATs and therefore stress the heavy 
burden of psychopathology associated with ATs in 
both referred and non-referred youth. These findings 
are also in line with the prevailing literature, which 
highlights higher-than-expected rates of major 
psychiatric disorders among youth with ASD (22-24). 
Also consistent with previously reported findings 
in probands with ADHD (6) is that non-referred 
siblings with ATs experienced greater social and 
interpersonal deficits as manifested by significantly 
worse GAF scores, significantly more impaired 
CBCL social and school competence scores, 
significantly more impaired SAICA scores, and 
Autistic Traits in non-referred Youth 
 
 
85 
 
higher rates of social disability as compared with 
siblings without ATs. Taken together, these findings 
provide further evidence that ATs severely affect the 
social functioning of afflicted children, irrespective 
of referral status. 
Although the results did not reach our a priori 
threshold for statistical significance, we found that 
non-referred siblings with ATs had similarly lower 
full-scale intelligence quotients, Freedom from 
Distractibility intelligence quotients, and Block 
Design and Digit Symbol WISC-R scores as well as 
lower WRAT-R reading and arithmetic scores. These 
findings, which mirror what we reported for 
probands with ADHD, suggest that neurocognitive 
functioning is compromised in the presence of ATs. 
Also in line with the findings reported for 
probands with ADHD is that non-referred children 
with ATs had higher rates of most pregnancy and 
infancy complications as compared with those of 
other children without ATs. These findings further 
support the hypothesis that perinatal complications 
alone—or in combination with genetic risk 
factors—could account for the development of ATs 
in some children.  
Extending findings related to ATs to non-referred 
children has important clinical and scientific 
implications. Documenting the broad and severe 
spectrum of morbidity and dysfunction associated 
with ATs in non-referred youth supports the clinical 
relevance of ATs independent of referral status. 
Considering how easy it is to screen for ATs with the 
use of the CBCL, clinicians in the community have 
access to a rapid, inexpensive, and informative tool 
to screen children in clinical practice. Significant 
morbidity and dysfunction are associated with ATs, 
so the ability to identify children with ATs may 
facilitate the development of appropriate 
interventions that target afflicted children. This 
knowledge will help to inform future research aimed 
at identifying distinct genetic, neural, and therapeutic 
targets related to ATs.  
The present study contains several strengths. Most 
notably, it relies on a large number of non-referred 
youth and an operationalized definition of ATs that 
is based on a unique profile of the empirically derived 
CBCL for the identification of ATs, which can be 
easily used in the clinical setting.  
However, our findings need to be viewed in light 
of certain limitations. Despite the strength of the 
findings, our sample of non-referred siblings with 
ATs was relatively small. Although ATs were more 
strongly associated with ADHD, the sample size was 
too small to allow for a separate analysis limited to 
siblings with ADHD. Because we lacked an adequate 
sample of siblings of control probands with ATs, the 
analysis was limited to siblings of probands with 
ADHD. Although autism was excluded in the 
probands, it was not systematically ruled out in the 
siblings, thereby allowing for the possibility that 
some of the children may have had undiagnosed 
ASD. Although this analysis was limited to the 
siblings of probands with ADHD with and without 
ATs, we have previously documented the high 
discriminant validity of the CBCL-AT profile for the 
identification of ASD in a psychiatrically referred 
population of youth. (5) It is also notable that the 
presence of ATs in the siblings of children with 
ADHD was associated with lower SES, even though 
the analysis was controlled for social class. The 
present findings are in line with our previous report 
of poorer SES being more highly associated with 
children with ADHD with ATs than without ATs 
(6). Our findings are consistent with those of the 
prevailing literature, which suggest a higher 
association of ASD with low SES (25). Furthermore, 
we found a lower rate of accidents during pregnancy 
among siblings with ATs. This was an unexpected 
finding, so additional studies are needed to verify this 
result. Finally, our sample was largely Caucasian, but 
our findings may not generalize to other ethnic 
groups.  
Despite these considerations, our work shows that 
ATs can be identified in a sizeable minority of non-
referred children and that these children are at high 
risk for significant morbidity and disability. More 
work is needed to replicate these findings and to 
further examine their prognostic usefulness. 
 
Clinical Significance 
The current findings suggest that elevated scores on 
the CBCL-AT subscale may indicate a need to 
clinically assess a child for ASD and ADHD; mood, 
anxiety, and disruptive behavior disorders; 
emotional dysregulation; and impaired social and 
school functioning. 
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